UK experience of treosulfan-based conditioning regimens in children with primary immunodeficiency

被引：0
|
作者：
Slatter, M. [1 ]
Rao, K. [2 ]
Amrolia, P. [2 ]
Flood, T.
Abinun, M. [1 ]
Cant, A. [1 ]
Hambleton, S. [3 ]
Goulden, N. [2 ]
Davies, G. [2 ]
Qasim, W. [2 ]
Gasper, H. B. [2 ]
Gennery, A. [1 ]
Veys, P. [2 ]
机构：
[1] Newcastle Upon Tyne Hosp NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England
[2] Great Ormond St Hosp NHS Trust, London, England
[3] Newcastle Univ, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
来源：
BONE MARROW TRANSPLANTATION | 2010年 / 45卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S73 / S74
页数：2
相关论文
共 50 条
  • [1] UK EXPERIENCE OF TREOSULFAN-BASED CONDITIONING REGIMENS IN CHILDREN WITH PRIMARY IMMUNODEFICIENCY OR SEVERE IMMUNE DYSREGULATION
    Slatter, M.
    Rao, K.
    Amrolia, P.
    Flood, T.
    Abinun, M.
    Cant, A.
    Hambleton, S.
    Goulden, N.
    Gennery, A.
    Veys, P.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S184 - S184
  • [2] Treosulfan-based conditioning regimens for hematopoietic stem cell transplantation in children with primary immunodeficiency: United Kingdom experience
    Slatter, Mary A.
    Rao, Kanchan
    Amrolia, Persis
    Flood, Terry
    Abinun, Mario
    Hambleton, Sophie
    Nademi, Zohreh
    Goulden, Nick
    Davies, Graham
    Qasim, Waseem
    Gaspar, Hubert B.
    Cant, Andrew
    Gennery, Andrew R.
    Veys, Paul
    BLOOD, 2011, 117 (16) : 4367 - 4375
  • [3] Treosulfan-based conditioning for children with nonmalignant disease: the Hannover experience
    Maecker, B.
    Sauer, M.
    Meissner, B.
    Welte, K.
    Sykora, K. W.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S299 - S299
  • [4] Treosulfan-based conditioning regimens for allogeneic HSCT in children with acute lymphoblastic leukaemia
    Heidrun Boztug
    Marco Zecca
    Karl-Walter Sykora
    Paul Veys
    Arjan Lankester
    Mary Slatter
    Roderick Skinner
    Jacek Wachowiak
    Ulrike Pötschger
    Evgenia Glogova
    Christina Peters
    Annals of Hematology, 2015, 94 : 297 - 306
  • [5] Treosulfan-based conditioning regimens for allogeneic HSCT in children with acute lymphoblastic leukaemia
    Boztug, Heidrun
    Zecca, Marco
    Sykora, Karl-Walter
    Veys, Paul
    Lankester, Arjan
    Slatter, Mary
    Skinner, Roderick
    Wachowiak, Jacek
    Poetschger, Ulrike
    Glogova, Evgenia
    Peters, Christina
    ANNALS OF HEMATOLOGY, 2015, 94 (02) : 297 - 306
  • [6] Treosulfan-based conditioning in children: retrospective analysis of the German and Austrian experience
    Beier, R.
    Schulz, A.
    Hoenig, M.
    Schlegel, G.
    Holter, W.
    Stachel, D.
    Ehlert, K.
    Greil, J.
    Nuernberger, W.
    Bader, P.
    Urban, C.
    Mueller, I.
    Suttorp, M.
    Buechner, J.
    Sauer, M.
    Sykora, K. W.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S50 - S50
  • [7] Treosulfan and Fludarabine Conditioning for Hematopoietic Stem Cell Transplantation in Children with Primary Immunodeficiency: UK Experience
    Slatter, Mary A.
    Rao, Kanchan
    Abd Hamid, Intan Juliana
    Nademi, Zohreh
    Chiesa, Robert
    Elfeky, Reem
    Pearce, Mark S.
    Amrolia, Persis
    Worth, Austen
    Flood, Terence
    Abinun, Mario
    Hambleton, Sophie
    Qasim, Waseem
    Gaspar, Hubert B.
    Cant, Andrew J.
    Gennery, Andrew R.
    Veys, Paul
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : 529 - 536
  • [8] Treosulfan, fludarabine and alemtuzumab conditioning for haematopoietic stem cell transplantation in children with primary immunodeficiency: UK experience
    Slatter, M.
    Rao, K.
    Nademi, Z.
    Chiesa, R.
    Amrolia, P.
    Flood, T.
    Abinun, M.
    Cant, A.
    Hambleton, S.
    Davies, G.
    Qasim, W.
    Gaspar, B.
    Gennery, A.
    Veys, P.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S265 - S265
  • [9] TREOSULFAN, FLUDARABINE AND ALEMTUZUMAB CONDITIONING FOR HEMATOPOIETIC STEM CELL TRANSPLANTATION IN CHILDREN WITH PRIMARY IMMUNODEFICIENCY: UK EXPERIENCE
    Slatter, M.
    Rao, K.
    Chiesa, R.
    Amrolia, P.
    Nademi, Z.
    Flood, T.
    Abinun, M.
    Cant, A.
    Hambleton, J.
    Goulden, N.
    Davies, G.
    Qasim, W.
    Gaspar, H. B.
    Gennay, A.
    Veys, P.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S234 - S234
  • [10] TREOSULFAN, FLUDARABINE AND ALEMTUZUMAB CONDITIONING FOR HEMATOPOIETIC STEM CELL TRANSPLANTATION IN CHILDREN WITH PRIMARY IMMUNODEFICIENCY: UK EXPERIENCE
    Slatter, M.
    Rao, K.
    Nademi, Z.
    Chiesa, R.
    Amrolia, P.
    Flood, T.
    Abinun, M.
    Cant, A.
    Hambleton, S.
    Allwood, Z.
    Skinner, R.
    Samarasinghe, S.
    Nikolajeva, O.
    Qasim, W.
    Gaspar, H.
    Gennery, A.
    Veys, P.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S44 - S44
12345